Certified by Founder Lodge
Bristol Myers Squibb
United States - Lawrence Township, NJ
INVESTOR
1 Disclosed Funding Rounds $105,000,000
25 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
At Bristol Myers Squibb, we work every day to transform patients’ lives through science. That work inspires some of the most interesting, meaningful, and life-changing careers you’ll experien
| Company | Date | Round | Raised |
|---|---|---|---|
 Pathios Therapeutics |
April, 19 ,2024 | Series B | $25,000,000 |
 Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
 Mediar Therapeutics |
March, 15 ,2023 | Unknown | $105,000,000 |
| Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
 Cellares |
August, 24 ,2023 | Series C | $255,000,000 |
 Envisagenics |
June, 06 ,2024 | Series B | |
 Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
 AstronauTx |
October, 09 ,2023 | Series A | $58,462,000 |
 Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
| Pathios Therapeutics |
April, 19 ,2024 | Series B | $25,000,000 |
| Pathios Therapeutics |
April, 19 ,2024 | Series B | $25,000,000 |
| Capstan Therapeutics |
March, 21 ,2024 | Series B | $175,000,000 |
| Envisagenics |
June, 06 ,2024 | Series B | |
| Envisagenics |
June, 06 ,2024 | Series B | |
| Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
| Asher Biotherapeutics |
April, 17 ,2024 | Series C | $55,000,000 |
 Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
 Dispatch Bio |
July, 24 ,2025 | Series A | |
| Pathios Therapeutics |
April, 19 ,2024 | Series B | $25,000,000 |
| Envisagenics |
June, 06 ,2024 | Series B | |
| Outpace Bio |
August, 02 ,2024 | Series B | $144,000,000 |
| Be Biopharma |
October, 23 ,2024 | Unknown | $82,000,000 |
| Dispatch Bio |
July, 24 ,2025 | Series A |
Truemeds India
Receptor Life Sciences, Inc.
Koneksa
MAYD: MEDS AT YOUR DOORSTEP
Fullife Healthcare Pvt. Ltd.
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
